The diagnostic blind spot of spirometric staging in biomass-related non-smoking chronic obstructive pulmonary disease: a cross-sectional study of spirometry-diffusion discordance in a rural South Indian population
Abstract
Chronic obstructive pulmonary disease (COPD) is heterogeneous, yet severity is conventionally graded by spirometry [forced expiratory volume in 1 second (FEV1)] on the assumption that airflow limitation reflects parenchymal damage. Biomass-related non-smoking COPD (NS-COPD) is common in low- and middle-income countries. In this hospital-based cross-sectional study, we compared the physiological phenotypes of smoking COPD (S-COPD) and biomass-related NS-COPD and tested the concordance between Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometric severity and diffusion-based gas-exchange impairment. A total of 91 stable COPD patients (S-COPD, n=54; NS-COPD, n=37) underwent post-bronchodilator spirometry, single-breath diffusing capacity of the lung for carbon monoxide (DLCO) with transfer coefficient (KCO), residual volume to total lung capacity ratio, and the 6-minute walk test; cohorts were stratified by exposure (>10 pack-years vs. >60 hour-years of biomass) and compared using the Student t-test and Fisher's exact test. Compared with smokers, non-smokers had higher DLCO (71.4±12.4 vs. 57.7±17.5% predicted; p<0.001) and KCO (0.95±0.19 vs. 0.71±0.22 mmol/min/kPa/L; p<0.001). All non-smokers with severe (GOLD 3) airflow limitation (8/8, 100%) retained normal or only mildly impaired diffusion [7/8 (87.5%) strictly normal], whereas 14/28 (50.0%) GOLD 3 smokers had impaired gas exchange [4/28 (14.3%) severe]. Non-smokers more often retained a normal DLCO [31/37 (83.8%) vs. 26/54 (48.1%); odds ratio 5.6, 95% confidence interval 2.0-15.5; p<0.001]. This difference persisted after multivariable adjustment for age, sex and body mass index (odds ratio 30.0, 95% confidence interval 2.5-358.5; p=0.007) and after further adjustment for FEV1 percent predicted (odds ratio 21.1, 95% confidence interval 1.6-282.7; p=0.021), indicating that the dissociation was not explained by these covariates or by the degree of airflow limitation itself. GOLD staging tended to overestimate parenchymal severity in biomass-related NS-COPD, in which airflow obstruction was largely uncoupled from gas-exchange loss, whereas in smokers the two were more tightly coupled. These cross-sectional, single-center findings, limited by a sex imbalance and the absence of imaging confirmation, support routine DLCO/KCO measurement to phenotype these patients and, where imaging is scarce, as a low-cost structural surrogate.
Ethics Approval
This study was approved by the Adichunchanagiri Institute of Medical Sciences Institutional Ethics Committee (approval number AIMS/IEC/040/2024; Ethics Committee registration number EC/NEW/INST/2023/KA/0382) on 2 April 2024, and was conducted in accordance with the Declaration of Helsinki (2013 revision).
References
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2024 report). Available from: https://goldcopd.org/2024-gold-report/
- Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-43. DOI: https://doi.org/10.1016/S0140-6736(09)61303-9
- Jindal SK, Aggarwal AN, Gupta D, et al. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012;16:1270-7. DOI: https://doi.org/10.5588/ijtld.12.0005
- Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017;49:1600016. DOI: https://doi.org/10.1183/13993003.00016-2016
- Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med 2017;195:557-82. DOI: https://doi.org/10.1164/rccm.201701-0218PP
- Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001;56:880-7. DOI: https://doi.org/10.1136/thorax.56.11.880
- Topalovic M, Exadaktylos V, Peeters A, et al. Computer quantification of airway collapse on forced expiration to predict the presence of emphysema. Respir Res 2013;14:131. DOI: https://doi.org/10.1186/1465-9921-14-131
- Sheikh K, Coxson HO, Parraga G. This is what COPD looks like. Respirology 2016;21:224-36. DOI: https://doi.org/10.1111/resp.12611
- Dal Negro RW, Turco P, Povero M. Sensitivity and specificity of various lung function parameters recommended for phenotyping COPD in clinical practice. Respir Med 2025;246:108256. DOI: https://doi.org/10.1016/j.rmed.2025.108256
- Zavorsky GS, Barisione G, Gille T, et al. Enhanced detection of patients with previous COVID-19: superiority of the double diffusion technique. BMJ Open Respir Res 2025;12:e002561. DOI: https://doi.org/10.1136/bmjresp-2024-002561
- Camp PG, Ramirez-Venegas A, Sansores RH, et al. COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J 2014;43:725-34. DOI: https://doi.org/10.1183/09031936.00206112
- Zhao D, Zhou Y, Jiang C, et al. Small airway disease: a different phenotype of early stage COPD associated with biomass smoke exposure. Respirology 2018;23:198-205. DOI: https://doi.org/10.1111/resp.13176
- Mahesh PA, Jayaraj BS, Prabhakar AK, et al. Identification of a threshold for biomass exposure index for chronic bronchitis in rural women of Mysore district, Karnataka, India. Indian J Med Res 2013;137:87-94.
- Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1428-46. DOI: https://doi.org/10.1183/09031936.00150314
- Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68. DOI: https://doi.org/10.1183/09031936.05.00035205
- Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022;60:2101499. DOI: https://doi.org/10.1183/13993003.01499-2021
- Golpe R, Sanjuán López P, Cano Jiménez E, et al. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol 2014;50:318-24. DOI: https://doi.org/10.1016/j.arbr.2014.06.003
- Olloquequi J, Jaime S, Parra V, et al. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both. Respir Res 2018;19:13. DOI: https://doi.org/10.1186/s12931-018-0718-y
- Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011;139:752-63. DOI: https://doi.org/10.1378/chest.10-1253
- Agusti A, Bafadhel M, Beasley R, et al. Precision medicine in airway diseases: moving to clinical practice. Eur Respir J 2017;50:1701655. DOI: https://doi.org/10.1183/13993003.01655-2017
- Smith BM, Kirby M, Hoffman EA, et al. Association of dysanapsis with chronic obstructive pulmonary disease among older adults. JAMA 2020;323:2268-80. DOI: https://doi.org/10.1001/jama.2020.6918
- Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53. DOI: https://doi.org/10.1056/NEJMoa032158
- India State-Level Disease Burden Initiative CRD Collaborators. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016. Lancet Glob Health 2018;6:e1363-74.
- Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-73. DOI: https://doi.org/10.1016/S0140-6736(07)61380-4
- Rivera RM, Cosio MG, Ghezzo H, et al. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 2008;12:972-7.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.